These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23266114)

  • 1. Efficacy of dietary therapy for juvenile myoclonic epilepsy.
    Kossoff EH; Henry BJ; Cervenka MC
    Epilepsy Behav; 2013 Feb; 26(2):162-4. PubMed ID: 23266114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-mail management of the modified Atkins Diet for adults with epilepsy is feasible and effective.
    Cervenka MC; Terao NN; Bosarge JL; Henry BJ; Klees AA; Morrison PF; Kossoff EH
    Epilepsia; 2012 Apr; 53(4):728-32. PubMed ID: 22332768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of the modified Atkins diet for intractable epilepsy in adults.
    Kossoff EH; Rowley H; Sinha SR; Vining EP
    Epilepsia; 2008 Feb; 49(2):316-9. PubMed ID: 17919301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy.
    Kverneland M; Selmer KK; Nakken KO; Iversen PO; Taubøll E
    Epilepsy Behav; 2015 Dec; 53():197-201. PubMed ID: 26588588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.
    Senf P; Schmitz B; Holtkamp M; Janz D
    Neurology; 2013 Dec; 81(24):2128-33. PubMed ID: 24212391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients with absence epilepsy respond to ketogenic diets?
    Groomes LB; Pyzik PL; Turner Z; Dorward JL; Goode VH; Kossoff EH
    J Child Neurol; 2011 Feb; 26(2):160-5. PubMed ID: 20647578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy.
    Kossoff EH; McGrogan JR; Bluml RM; Pillas DJ; Rubenstein JE; Vining EP
    Epilepsia; 2006 Feb; 47(2):421-4. PubMed ID: 16499770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
    Asadi-Pooya AA; Hashemzehi Z; Emami M
    Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danish study of a modified Atkins diet for medically intractable epilepsy in children: can we achieve the same results as with the classical ketogenic diet?
    Miranda MJ; Mortensen M; Povlsen JH; Nielsen H; Beniczky S
    Seizure; 2011 Mar; 20(2):151-5. PubMed ID: 21126887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide treatment of juvenile myoclonic epilepsy.
    Afra P; Adamolekun B
    Seizure; 2012 Apr; 21(3):202-4. PubMed ID: 22281192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
    Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
    Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Atkins diet in children with epilepsy with eyelid myoclonia (Jeavons syndrome).
    Paibool W; Schimpf S; Nordli DR; Phitsanuwong C
    Epilepsy Behav; 2023 Aug; 145():109347. PubMed ID: 37459720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
    Fernando-Dongas MC; Radtke RA; VanLandingham KE; Husain AM
    Seizure; 2000 Sep; 9(6):385-8. PubMed ID: 10985993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
    Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
    Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years.
    Syvertsen MR; Thuve S; Stordrange BS; Brodtkorb E
    Seizure; 2014 May; 23(5):344-8. PubMed ID: 24512779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Atkins diet is an effective treatment for children with Doose syndrome.
    Wiemer-Kruel A; Haberlandt E; Hartmann H; Wohlrab G; Bast T
    Epilepsia; 2017 Apr; 58(4):657-662. PubMed ID: 28229464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.